Yu-Shin Ding

Author PubWeight™ 60.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage 2008 2.86
2 Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. J Neurosci 2005 2.41
3 "Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse 2002 2.13
4 Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci 2003 2.08
5 Brain dopamine is associated with eating behaviors in humans. Int J Eat Disord 2003 1.80
6 Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Synapse 2002 1.56
7 Comparison of monoamine oxidase a in peripheral organs in nonsmokers and smokers. J Nucl Med 2005 1.53
8 Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo. Biol Psychiatry 2010 1.44
9 Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biol Psychiatry 2005 1.43
10 Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse 2002 1.38
11 Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study. Psychiatry Res 2002 1.33
12 Kinetic modeling of the serotonin 5-HT(1B) receptor radioligand [(11)C]P943 in humans. J Cereb Blood Flow Metab 2009 1.19
13 Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma. Psychopharmacology (Berl) 2003 1.16
14 Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleus. JAMA Psychiatry 2013 1.14
15 Affinity and selectivity of [¹¹C]-(+)-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo. Synapse 2012 1.14
16 Pancreatic beta cell mass PET imaging and quantification with [11C]DTBZ and [18F]FP-(+)-DTBZ in rodent models of diabetes. Mol Imaging Biol 2010 1.14
17 Imaging the norepinephrine transporter in humans with (S,S)-[11C]O-methyl reboxetine and PET: problems and progress. Nucl Med Biol 2007 1.14
18 Endotoxin-induced systemic inflammation activates microglia: [¹¹C]PBR28 positron emission tomography in nonhuman primates. Neuroimage 2012 1.08
19 Synthesis and evaluation of [18F]exendin (9-39) as a potential biomarker to measure pancreatic β-cell mass. Nucl Med Biol 2011 1.08
20 High-resolution imaging of brain 5-HT 1B receptors in the rhesus monkey using [11C]P943. Nucl Med Biol 2009 1.03
21 Serotonin 1B receptor imaging in alcohol dependence. Biol Psychiatry 2010 1.02
22 In vivo imaging of endogenous pancreatic β-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET. J Nucl Med 2012 1.01
23 Kinetic analysis of the metabotropic glutamate subtype 5 tracer [(18)F]FPEB in bolus and bolus-plus-constant-infusion studies in humans. J Cereb Blood Flow Metab 2012 1.01
24 Radiosynthesis and in vivo evaluation of [(11)C]MP-10 as a positron emission tomography radioligand for phosphodiesterase 10A. Nucl Med Biol 2011 1.00
25 Evaluation of [(11)C]MRB for assessment of occupancy of norepinephrine transporters: Studies with atomoxetine in non-human primates. Neuroimage 2010 0.99
26 The effect of early trauma exposure on serotonin type 1B receptor expression revealed by reduced selective radioligand binding. Arch Gen Psychiatry 2011 0.95
27 Maternal and fetal 11C-cocaine uptake and kinetics measured in vivo by combined PET and MRI in pregnant nonhuman primates. J Nucl Med 2005 0.94
28 Synthesis and positron emission tomography studies of carbon-11-labeled imatinib (Gleevec). Nucl Med Biol 2007 0.93
29 Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region. Nucl Med Biol 2005 0.92
30 Normative database of the serotonergic system in healthy subjects using multi-tracer PET. Neuroimage 2012 0.92
31 Determination of in vivo Bmax and Kd for 11C-GR103545, an agonist PET tracer for κ-opioid receptors: a study in nonhuman primates. J Nucl Med 2013 0.89
32 [11C]GR103545: novel one-pot radiosynthesis with high specific activity. Nucl Med Biol 2010 0.88
33 Increased error-related thalamic activity during early compared to late cocaine abstinence. Drug Alcohol Depend 2010 0.88
34 Ex vivo and in vivo evaluation of the norepinephrine transporter ligand [11C]MRB for brown adipose tissue imaging. Nucl Med Biol 2012 0.87
35 Monoamine oxidase: radiotracer development and human studies. Methods 2002 0.86
36 Low monoamine oxidase B in peripheral organs in smokers. Proc Natl Acad Sci U S A 2003 0.86
37 Synthesis, enantiomeric resolution, F-18 labeling and biodistribution of reboxetine analogs: promising radioligands for imaging the norepinephrine transporter with positron emission tomography. Nucl Med Biol 2005 0.85
38 Test-retest reproducibility of [11C]-(+)-propyl-hexahydro-naphtho-oxazin positron emission tomography using the bolus plus constant infusion paradigm. Mol Imaging 2013 0.84
39 Synthesis and PET studies of [(11)C-cyano]letrozole (Femara), an aromatase inhibitor drug. Nucl Med Biol 2009 0.84
40 PET imaging of monoamine oxidase B in peripheral organs in humans. J Nucl Med 2002 0.84
41 Strategy for the formation of parametric images under conditions of low injected radioactivity applied to PET studies with the irreversible monoamine oxidase A tracers [11C]clorgyline and deuterium-substituted [11C]clorgyline. J Cereb Blood Flow Metab 2002 0.84
42 Synthesis, enantiomeric resolution, and selective C-11 methylation of a highly selective radioligand for imaging the norepinephrine transporter with positron emission tomography. Chirality 2004 0.83
43 Synthesis of no-carrier-added C-11 labeled D- and L-enantiomers of phenylalanine and tyrosine for comparative PET Studies. Nucl Med Biol 2003 0.83
44 PET imaging in clinical drug abuse research. Curr Pharm Des 2005 0.82
45 The slow and long-lasting blockade of dopamine transporters in human brain induced by the new antidepressant drug radafaxine predict poor reinforcing effects. Biol Psychiatry 2005 0.82
46 Comparison of the binding of the irreversible monoamine oxidase tracers, [(11)C]clorgyline and [(11)C]l-deprenyl in brain and peripheral organs in humans. Nucl Med Biol 2004 0.82
47 Synthesis and evaluation of inhaled [11C]butane and intravenously injected [11C]acetone as potential radiotracers for studying inhalant abuse. Nucl Med Biol 2005 0.82
48 Synthesis of structurally identical fluorine-18 and iodine isotope labeling compounds for comparative imaging. Bioconjug Chem 2003 0.81
49 Synthesis and C-11 labeling of three potent norepinephrine transporter selective ligands ((R)-nisoxetine, lortalamine, and oxaprotiline) for comparative PET studies in baboons. Bioorg Med Chem 2005 0.80
50 Candidate PET radioligands for cannabinoid CB1 receptors: [18F]AM5144 and related pyrazole compounds. Nucl Med Biol 2005 0.79
51 Radiotracers for positron emission tomography imaging. Semin Nucl Med 2003 0.79
52 Age effects on serotonin receptor 1B as assessed by PET. J Nucl Med 2012 0.78
53 Comparison of the pharmacokinetics of different analogs of 11C-labeled TZTP for imaging muscarinic M2 receptors with PET. Nucl Med Biol 2008 0.78
54 Quantitative graphical analysis of simultaneous dynamic PET/MRI for assessment of prostate cancer. Clin Nucl Med 2015 0.77
55 Test-retest reproducibility of the metabotropic glutamate receptor 5 ligand [¹⁸F]FPEB with bolus plus constant infusion in humans. Eur J Nucl Med Mol Imaging 2015 0.77
56 Monoamine oxidase A imaging in peripheral organs in healthy human subjects. Synapse 2003 0.76
57 Synthesis and positron emission tomography studies of C-11-labeled isotopomers and metabolites of GTS-21, a partial alpha7 nicotinic cholinergic agonist drug. Nucl Med Biol 2007 0.75
58 2-deoxy-2-[18F]fluoro-D-glucose and alternative radiotracers for positron emission tomography imaging using the human brain as a model. Semin Nucl Med 2004 0.75